FDA rejects again Alimera eye implant; shares plunge

FDA rejects again Alimera eye implant; shares plunge

The FDA raised concerns about the eye implant's safety profile in its complete response letter rejecting marketing approval, the company said on Friday. Marketing approval is the final OK needed to start selling a medical device in the United States

3
Like
Save

Comments

Write a comment

*